Company: NUTR
Filing Date: 2025-03-21
Form Type: S-1
Source: 0001641172-25-000122
Chunk: 58

Company: NUSATRIP Inc
Filing Date: 2025-03-21
Form: S-1
Chunk 58
---
 to receive net proceeds of approximately $12,120,000 (offering proceeds of $13,500,000,                                                                                                                
 less underwriting discounts of $945,000, non-accountable expense of 135,000 and offering expenses of $300,000 which                                                                                                                            
 $263,194 have paid). The shares of Common Stock reflects the issuance and sale of 3,000,000 shares of Common Stock at an assumed                                                                                                               
 initial public offering price of $4.50 per share after deducting underwriting discounts, Underwriter expense allowance and other                                                                                                               
 expenses.                                                                                                                                                                                                                                      |
| (2) | Pro                                                                                                                                                                                                                                            
 forma as adjusted additional paid in capital reflects the net proceeds we expect to receive, after deducting underwriting fee, underwriter                                                                                                     
 expense allowance and other expenses. We expect to receive net proceeds of approximately $13,720,002 (offering proceeds of                                                                                                                     
 $13,500,000 plus the total consideration of $1,600,002 to be paid for the conversion of the Convertible Notes, less underwriting                                                                                                               
 discounts of $945,000, non-accountable expense of 135,000 and offering expenses of $300,000 which $263,194 have paid). The shares of Common Stock reflects the (i) issuance and sale of 3,000,000 shares of Common Stock at an assumed initial 
 public offering price of $4.50 per share and (ii) issuance and sales of 1,066,668 shares of Common Stock at an assumed price of $1.50                                                                                                          
 after deducting underwriting discounts, Underwriter expense allowance and other expenses.                                                                                                                                                      |

| 38 |

<div align='center'>DILUTION</div>

If you invest in our Shares, your interest will be diluted to the extent of the difference between the IPO offering price per share and our net tangible book value per share after the IPO. Dilution results from the fact that the IPO offering price per share is substantially in excess of the book value per share of Common Stock attributable to the existing stockholders for our presently outstanding shares.

Net tangible book value represents the amount of our total assets, excluding goodwill and other intangible assets, less our total liabilities. Our net tangible book value as of December 31, 2024 was US$(5,981,709), or US$(0.43) per share of Common Stock.

After giving effect to the issuance and sale of 1,066,668 shares of common